Specialty Ingredient

β-NMN Manufacturer & Bulk NMN Powder Supplier

Gensei supplies β-Nicotinamide Mononucleotide (NMN) as a fine powder for ingredient evaluation and supplement formulation. The product is supported by batch-level analytical data, specification review, sample coordination and commercial packaging information.

β-Nicotinamide Mononucleotide (NMN) powder

Product Information

β-NMN at a Glance

A clear product definition for material review before sample approval or commercial sourcing.

Ingredient β-Nicotinamide Mononucleotide (NMN)
Ingredient Role NAD+ precursor
Supply Format Fine powder
Quality Basis Batch-level analytical data

Product Overview

What Matters When Reviewing β-NMN

For ingredient qualification, the useful comparison is not purity alone. Identity, assay basis, impurity controls, physical properties and microbiological results should be reviewed together.

Identity & Assay

The supplied material is identified as β-Nicotinamide Mononucleotide (NMN). The COA separates assay reported on an anhydrous basis from chromatographic area purity, so the two values can be reviewed for different analytical purposes.

Contaminant & Microbial Control

The batch record includes heavy metals, individual elemental contaminants, sodium residue, pesticide residues, ethanol and microbiological parameters, allowing a more complete review of the material than a single purity number.

Product Batch

β-NMN Batch Information

Product β-Nicotinamide Mononucleotide (NMN)
Batch No. NA-NMN-26021012-1
Representative Qty. 1000 kg
Manufacture Date Feb. 10, 2026
Expiry Date Feb. 09, 2028

Technical Specification

β-NMN Specification & COA Results

The following results are taken from the supplied Certificate of Analysis for the batch shown above.

Test Item Specification Test Method Result
Description
Appearance Pure white fine powder Visual Complies
Odor Characteristic Sensory Complies
Taste Characteristic Sensory Complies
Loss on Drying ≤ 1.0% 2g/105℃/5hrs 0.12%
Bulk Density / W/V 0.64 g/ml
pH (1mg/1ml water) 2.0 - 4.0 pH meter 3.4
Assay
Assay (on the anhydrous basis) ≥ 98% HPLC 99.20%
Purity (area%) ≥ 99.5% HPLC 99.90%
Contaminants
Heavy Metals ≤ 10 ppm Colorimetric method Complies
Arsenic (As) ≤ 0.5 ppm AFS Complies
Lead (Pb) ≤ 0.5 ppm AFS Complies
Cadmium (Cd) ≤ 0.1 ppm AFS Complies
Mercury (Hg) ≤ 0.1 ppm AFS Complies
Na+ Residue ≤ 1.0% IC Complies
Pesticides Residues Meet USP LC-MSMS/GC-MS Complies
Ethanol ≤ 5000 ppm GC Complies
Microbiological
Total microbacterial count ≤ 1000 CFU/g GB 4789.2 Complies
Yeast ≤ 100 CFU/g GB 4789.15 Complies
Mold ≤ 100 CFU/g GB 4789.15 Complies
E. Coli Negative GB 4789.38 Negative
Salmonella Negative GB 4789.4 Negative

Application Areas

Where β-NMN Fits in Product Development

The ingredient is commonly evaluated as a NAD+ precursor for supplement formats. Final formulation, dosage and market use should follow the applicable product requirements.

01

Capsules

Powder handling and bulk density are relevant when assessing capsule fill performance and finished-product manufacturing requirements.

02

Tablets

The ingredient can be reviewed as part of tablet development where the material specification and processing requirements are defined in advance.

03

Powder Formats

Powder blends and stick-style formats can be evaluated against material properties, stability needs and the intended finished-product process.

04

Custom Premixes

For multi-ingredient formulations, specification matching can be reviewed before a sample or pilot blend is prepared.

Ingredient Review

How to Evaluate a β-NMN Material

A useful material review starts with the intended finished product and then works backward to the raw-material specification.

Key Review Points

Use the points below to structure a first-pass ingredient review before moving into sample testing or a commercial order.

Identity Confirm the required NMN form and the analytical identity used for qualification.
Assay Basis Check whether the specification distinguishes assay on anhydrous basis from area purity.
Contaminant Profile Review elemental contaminants, pesticide residues, solvent residues and microbiological limits.
Finished-Product Fit Match physical properties and documentation to the intended dosage form and destination market.

Research Context

NMN is an NAD+ precursor that has been evaluated in randomized human studies. Published trials have reported increases in blood NAD+ measures, while findings for functional and metabolic outcomes vary by study, population and endpoint.

Packaging

25 kg / Drum

The supplied COA specifies paper drums with two food-grade poly bags inside. Net weight is 25 kg per drum.

25 kg / drum

Storage

Cool & Dry Conditions

  • Seal the package and keep the material in a cool, dry place.
  • Avoid direct sunlight during storage.
  • Shelf life is 24 months under the stated conditions and original packaging.

Documentation

Information for Material Qualification

The supplied batch record gives a practical starting point for technical review, while project-specific document requirements can be confirmed with the quotation.

Certificate of Analysis

Batch-level analytical results covering physical properties, assay, contaminants and microbiological parameters.

Specification Review

Review the target assay, impurity controls, physical parameters and finished-product requirements before ordering.

Sample Coordination

Share the intended application, target quantity and specification so sample and document requirements can be reviewed together.

β-NMN Ingredient Inquiry

Request β-NMN Pricing & Product Information

Send your required quantity, target specification, finished-product format and destination market. We can review the material requirements and align the quotation with the requested documents and packaging.

Specification COA Sample Quotation

Send Your Inquiry

    Scroll to Top